AGRX

Agile Therapeutics (AGRX)

Agile Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:AGRX

<< 이전 1 2 3 4 5 6 7 8 9 10 11 12 13 14 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2022/06/11	05:49	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGRX	Agile Therapeutics Inc
2022/06/11	05:47	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGRX	Agile Therapeutics Inc
2022/06/11	05:46	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGRX	Agile Therapeutics Inc
2022/06/11	05:46	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGRX	Agile Therapeutics Inc
2022/06/11	05:31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AGRX	Agile Therapeutics Inc
2022/05/24	20:31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AGRX	Agile Therapeutics Inc
2022/05/23	21:01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AGRX	Agile Therapeutics Inc
2022/05/17	21:01	GlobeNewswire Inc.	Agile Therapeutics to Present at The H.C. Wainwright Global Investment Conference	NASDAQ:AGRX	Agile Therapeutics Inc
2022/05/15	04:55	TipRanks	Maxim Group Maintains a Hold Rating on Agile Therapeutics (AGRX)	NASDAQ:AGRX	Agile Therapeutics Inc
2022/05/14	06:23	Edgar (US Regulatory)	Securities Registration Statement (s-1)	NASDAQ:AGRX	Agile Therapeutics Inc
2022/05/13	05:13	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AGRX	Agile Therapeutics Inc
2022/05/13	05:05	GlobeNewswire Inc.	Agile Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update	NASDAQ:AGRX	Agile Therapeutics Inc
2022/05/06	06:01	GlobeNewswire Inc.	Agile Therapeutics Announces Findings of First-Year Post-Marketing Pharmacovigilance in ACOG Poster Presentation	NASDAQ:AGRX	Agile Therapeutics Inc
2022/05/06	02:55	TipRanks	Agile Therapeutics (AGRX) Gets a Hold Rating from Maxim Group	NASDAQ:AGRX	Agile Therapeutics Inc
2022/05/03	20:30	GlobeNewswire Inc.	Agile Therapeutics to Report First Quarter 2022 Financial Results and Provide Business Update on Thursday, May 12, 2022	NASDAQ:AGRX	Agile Therapeutics Inc
2022/04/27	20:22	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AGRX	Agile Therapeutics Inc
2022/04/26	22:26	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AGRX	Agile Therapeutics Inc
2022/04/26	21:00	GlobeNewswire Inc.	Agile Therapeutics Announces 1-For-40 Reverse Stock Split	NASDAQ:AGRX	Agile Therapeutics Inc
2022/04/15	05:16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AGRX	Agile Therapeutics Inc
2022/04/14	20:30	GlobeNewswire Inc.	Agile Therapeutics Announces First Quarter 2022 Prescription Data for Twirla®	NASDAQ:AGRX	Agile Therapeutics Inc
2022/04/11	20:05	GlobeNewswire Inc.	Agile Therapeutics Receives $4.7M After Selling Net Operating Loss Tax Benefits Through New Jersey Economic Development Program	NASDAQ:AGRX	Agile Therapeutics Inc
2022/04/07	20:30	GlobeNewswire Inc.	Agile Therapeutics® Announces Poster Presentation at the 2022 Annual Clinical and Scientific Meeting of the American College of Obstetricians and Gynecologists (ACOG)	NASDAQ:AGRX	Agile Therapeutics Inc
2022/03/31	20:30	GlobeNewswire Inc.	Agile Therapeutics® Announces First Twirla® Commercial Targeting Gen Z	NASDAQ:AGRX	Agile Therapeutics Inc
2022/03/31	05:05	GlobeNewswire Inc.	Agile Therapeutics Reports Fourth Quarter & Full Year 2021 Financial Results and Provides Corporate Update	NASDAQ:AGRX	Agile Therapeutics Inc
2022/03/19	05:31	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:AGRX	Agile Therapeutics Inc
2022/03/16	06:04	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AGRX	Agile Therapeutics Inc
2022/03/15	07:07	GlobeNewswire Inc.	Agile Therapeutics Announces Closing of $4.85 Million Registered Direct Offering	NASDAQ:AGRX	Agile Therapeutics Inc
2022/03/14	21:00	GlobeNewswire Inc.	Agile Therapeutics Announces $4.85 Million Registered Direct Offering	NASDAQ:AGRX	Agile Therapeutics Inc
2022/03/12	06:31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AGRX	Agile Therapeutics Inc
2022/03/11	22:01	GlobeNewswire Inc.	Agile Therapeutics to Participate in Upcoming March Investor Events	NASDAQ:AGRX	Agile Therapeutics Inc